# GENVOYA
> **NDA207561** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2015-11-05
## Drug
- **FDA Application Number:** NDA207561
- **Application type:** New Drug Application
- **Brand name:** GENVOYA
- **Generic name:** ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE
- **Active ingredients:** COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GILEAD SCIENCES INC
- **Manufacturer:** Gilead Sciences, Inc.
- **First approval:** 2015-11-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207561)
---
*MORVS · CC0 1.0*